Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesStatin discontinuation: an underestimated risk
Current Medical Research and Opinion, 11/21/08
Tziomalos K et al. - Statin treatment is essential for the prevention of vascular disease. Despite the established benefits of statins, discontinuation of these agents is frequent. Whether statin discontinuation leads to adverse outcomes is still debated and the most convincing evidence is mainly restricted to patients who experienced an acute vascular event. It is important to establish if this phenomenon extends to other populations, like those without vascular disease but with a high calculated risk.
Related Articles
Health behaviour models: a framework for studying adherence in children with atopic dermatitis
Clinical and Experimental Dermatology, 11/05/09
Relevance Score: 92%
Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence
Current Medical Research and Opinion, 10/05/09
Relevance Score: 91%
Interventions Improve Poor Adherence with Once Daily Glaucoma Medications in Electronically Monitored Patients
Ophthalmology, 10/08/09
Relevance Score: 90%
Adherence to Hydroxyurea Therapy in Children with Sickle Cell Anemia
The Journal of Pediatrics, 11/03/09
Relevance Score: 89%
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
Neuropsychiatric Disease and Treatment, 10/02/09
Relevance Score: 89%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Recent Caffeine Ingestion Reduces Adenosine Efficacy in the Treatment of Paroxysmal Supraventricular Tachycardia
Academic Emergency Medicine, 12/11/09
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor